BT063
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BT063, covering 2020-01-27 to 2020-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus [Phase 2]